CIRM Directors Moving on New Chairman and New Directions for Stem Cell Agency
Directors of the California stem cell agency are likely to settle this May on a new chairman of the $3 billion enterprise, replacing the man who has been the spirit behind the effort even before it was a gleam in voters' eyes.
The proposed timetable for election of a successor to Robert Klein, the first and only chair of CIRM, will come before directors…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.